M1A.2391 Drug-induced chronic gout, unspecified wrist, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Wrist, with Tophus (tophi)

Summary

Drug-induced chronic gout, unspecified wrist, with tophus (tophi) is a form of arthritis affecting the wrist joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the wrist area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the wrist joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense wrist pain, often with swelling and redness
• Persistent warmth and tenderness in the affected wrist
• Formation of tophi (hard, painless lumps) around the wrist joint
• Stiffness and limited range of motion in the wrist
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging to confirm urate crystal deposits. Synovial fluid analysis may identify monosodium urate crystals, while X-rays or ultrasound can detect tophi or joint damage. Medication history is critical to link the condition to drug-induced causes.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. This may include discontinuing or adjusting the causative medication, using urate-lowering therapies (e.g., allopurinol), anti-inflammatory drugs for pain relief, and local treatments for tophi if necessary.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and tophi may shrink or stabilize. Regular monitoring of uric acid levels and joint function is essential to prevent progression. Long-term follow-up ensures medication efficacy and addresses potential complications.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and increased tophi formation. Severe cases can result in functional impairment of the wrist or systemic complications from urate crystal deposition.

Lifestyle & Prevention

• Avoid or limit use of medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines and alcohol.
• Stay hydrated to support uric acid excretion.
• Follow prescribed urate-lowering therapy consistently.

When to Seek Professional Help

Seek medical attention if you experience severe or worsening wrist pain, swelling, or signs of infection (e.g., fever, redness). Prompt evaluation is necessary if tophi increase in size or number, or if joint function declines significantly.

Tips for Medical Coders

Document the presence of tophi and the unspecified wrist location clearly. Ensure the causative drug relationship is supported by clinical findings or medication history. Code M1A.2391 is specific to drug-induced chronic gout with tophus in the unspecified wrist; verify no laterality or additional site details are applicable.